Cargando…

BCAR4 activates GLI2 signaling in prostate cancer to contribute to castration resistance

Long non-coding RNAs (lncRNAs) have been found essential for tumorigenesis of prostate cancer (PC), but its role in the regulation of castration-resistant prostate cancer (CRPC) is poorly identified. Here, we showed that a lncRNA, Breast-Cancer Anti-Estrogen Resistance 4 (BCAR4), which plays a pivot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Zhiping, Wu, Yapei, Li, Yao, Ren, Jizhong, Wang, Linhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326698/ https://www.ncbi.nlm.nih.gov/pubmed/30513511 http://dx.doi.org/10.18632/aging.101664

Ejemplares similares

Role of BCAR4 in prostate cancer cell autophagy
por: Cai, Zhiping, et al.
Publicado: (2021)

Gli2 mediates the development of castration-resistant prostate cancer
por: Xia, Lu, et al.
Publicado: (2020)

Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression
por: Qiao, Jingbo, et al.
Publicado: (2016)

Genetic alterations in MED12 promote castration-resistant prostate cancer through modulation of GLI3 signaling
por: Duong, Thu Minh, et al.
Publicado: (2023)

BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
por: Godinho, M F E, et al.
Publicado: (2012)

The Value of LncRNA BCAR4 as a Prognostic Biomarker on Clinical Outcomes in Human Cancers
por: Tu, Chao, et al.
Publicado: (2019)

FLOT1 promotes gastric cancer progression and metastasis through BCAR1/ERK signaling
por: Wang, Ran, et al.
Publicado: (2023)

LncRNA BCAR4 promotes colon cancer progression via activating Wnt/β-catenin signaling
por: Ouyang, Shurui, et al.
Publicado: (2017)

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
por: Godinho, M F E, et al.
Publicado: (2010)

lncRNA BCAR4 Increases Viability, Invasion, and Migration of Non-Small Cell Lung Cancer Cells by Targeting Glioma-Associated Oncogene 2 (GLI2)
por: Yang, Hongliang, et al.
Publicado: (2019)

Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion
por: Guo, Alvin Kunyao, et al.
Publicado: (2020)

Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2
por: Bae, Kieun, et al.
Publicado: (2022)

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer
por: Heumann, Asmus, et al.
Publicado: (2018)

Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer
por: Batth, Izhar, et al.
Publicado: (2016)

Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance
por: Zhong, Shangwei, et al.
Publicado: (2021)

Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway
por: Dorssers, Lambert CJ, et al.
Publicado: (2005)

Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells
por: van Agthoven, Ton, et al.
Publicado: (2015)

GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer
por: Wan, Lilin, et al.
Publicado: (2023)

Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer
por: Zhao, Jingwen, et al.
Publicado: (2016)

β(2)‐adrenergic receptor signaling drives prostate cancer progression by targeting the Sonic hedgehog‐Gli1 signaling activation
por: Zhang, Mi, et al.
Publicado: (2020)

Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer
por: Ojo, Diane, et al.
Publicado: (2015)

Risk factors for progression to castration-resistant prostate cancer in metastatic prostate cancer patients
por: Lin, Ting-Ting, et al.
Publicado: (2019)

Investigating the role of BCAR4 in ovarian physiology and female fertility by genome editing in rabbit
por: Peyny, Maud, et al.
Publicado: (2020)

Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
por: Feng, Qin, et al.
Publicado: (2019)

Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer
por: Fontana, Fabrizio, et al.
Publicado: (2021)

Osteoclasts directly influence castration-resistant prostate cancer cells
por: Huang, Junchi, et al.
Publicado: (2022)

LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
por: Wu, Tangwei, et al.
Publicado: (2023)

Long non-coding RNA BCAR4 aggravated proliferation and migration in esophageal squamous cell carcinoma by negatively regulating p53/p21 signaling pathway
por: Yan, Shuo, et al.
Publicado: (2021)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Mai, Lixin, et al.
Publicado: (2020)

BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma
por: Mao, Chun-Guo, et al.
Publicado: (2021)

Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer
por: Yun, Seok Joong, et al.
Publicado: (2017)

The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer
por: Wang, Tao, et al.
Publicado: (2014)

PRKAR2B plays an oncogenic role in the castration-resistant prostate cancer
por: Sha, Jianjun, et al.
Publicado: (2016)

A fusion of CD63–BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis
por: Bae, Kieun, et al.
Publicado: (2020)

Pan-Cancer Analysis Reveals Recurrent BCAR4 Gene Fusions across Solid Tumors
por: Nickless, Andrew, et al.
Publicado: (2022)

Predicting castration-resistant prostate cancer after combined androgen blockade
por: He, Miao, et al.
Publicado: (2017)

Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer
por: Bremmer, Felix, et al.
Publicado: (2018)

Identification of marker genes and cell subtypes in castration-resistant prostate cancer cells
por: Lin, Xiao-Dan, et al.
Publicado: (2021)

Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014)

Darolutamide For Castration-Resistant Prostate Cancer
por: Bastos, Diogo A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v2f4m5dtinf3jdma5j30p0ced1